Desmopressin Acetate Spray Shortage: FDA Status Update
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Desmopressin Acetate Spray is currently in shortage according to the FDA, but it remains available from at least one manufacturer in its spray form.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 7, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Desmopressin Acetate Spray.
What's in Shortage
The drug in shortage is Desmopressin Acetate Spray, with the brand name DESMOPRESSIN ACETATE. It is a spray dosage form and is currently in shortage status. The therapeutic category is Hematology. This shortage was first posted on 03/12/2021 and last updated on 04/02/2026.
Which Manufacturers Are Affected
Apotex Corp. has the drug available. Their availability status is: Available. Presentation: Desmopressin Acetate (needs No Refrigeration), Spray, 10 ug (NDC 60505-0815-0). Contact information: 800-706-5575.
Why There's a Shortage
No specific reason was provided for the shortage.
What Patients Should Do
Patients should talk to their pharmacist or healthcare provider to check on the availability of this medication. They can also contact the manufacturer directly using the provided contact information. Please remember that patients should consult their healthcare provider for any medical advice or concerns; this article does not provide specific recommendations or alternatives.
Source
This information is attributed to the FDA Drug Shortage Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,106 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 7, 2026.
Frequently Asked Questions
Common questions about this FDA drug-shortage notice.